TB PRACTECAL | Behind the groundbreaking work to beat an overlooked crisis

TUBERCULOSIS: TB PRACTECAL - a cutting-edge clinical trialПодробнее

TB SILENT KILLER | Investigating the alarming rise of TuberculosisПодробнее

Multidrug-Resistant Tuberculosis (MDR-TB): Mycobacterium tuberculosisПодробнее

Current Concepts in Anti-Tuberculous TherapyПодробнее

Discovering and developing new treatments for tuberculosisПодробнее

Critical Path to TB Drug RegimensПодробнее

Inside the Epicenter of the TB Crisis | FRONTLINEПодробнее

TB PRACTECAL | A groundbreaking clinical trial to treat MDR-TBПодробнее

Taking on resistant TBПодробнее

New TB Treatment RegimensПодробнее

New combination TB drug shows promise of cutting treatment timeПодробнее

The Threat of Drug-Resistant TuberculosisПодробнее

MSF Aims for New TB TreatmentПодробнее

Implementing BPaL in US TB Programs: Developing a Science & Laboratory-informed ApproachПодробнее

The rise of tuberculosisПодробнее

WHO guideline on treatment of drug-resistant tuberculosis, 2022 updateПодробнее

Tatev's Story - Multi-Drug Resistant TuberculosisПодробнее

Tuberculosis - The Final Frontier: Pt. 3 - "Historic Opportunity for a New Treatment Regimen"Подробнее